There are 2789 resources available
357P - A phase II study of anlotinib in the treatment of recurrent high-grade glioma
Presenter: Hui Dai
Session: ePoster Display
358P - Anlotinib plus temozolomide for recurrent glioma: A single-center, retrospective study of 30 cases
Presenter: Yuandong Cao
Session: ePoster Display
359P - Regorafenib in recurrent glioblastoma patients: A large real-life experience
Presenter: Giuseppe Lombardi
Session: ePoster Display
360P - Metronomic temozolomide therapy in heavily pretreated patients with recurrent glioblastoma: A large mono-institutional retrospective study
Presenter: Vittorina Zagonel
Session: ePoster Display
413P - Butyrylcholinesterase as a predictive marker for wound infection in elective colorectal cancer surgery
Presenter: Francesk Mulita
Session: ePoster Display
414P - Does adjuvant chemotherapy compared to surveillance improve recurrence free and overall survival in stage 3 rectal cancer patients?
Presenter: Sola Adeleke
Session: ePoster Display
352P - The impact of carmustine implants and concurrent chemo-radiation on outcomes in primary treatment of glioblastoma: A single centre experience over a 10-year period
Presenter: Louise Price
Session: ePoster Display
8P - The characterization of tumors associated with the antitumor activity of lenvatinib plus anti-PD-1 antibody combination therapy in a mouse syngeneic model panel
Presenter: Yoichi Ozawa
Session: ePoster Display
9P - Click Activated Protodrugs Against Cancer (CAPAC) platform enhances the safety, pharmacokinetics, and antitumor efficacy of cancer therapies in vivo
Presenter: Sangeetha Srinivasan
Session: ePoster Display